A nanoemulsified formulation of dolutegravir and epigallocatechin gallate inhibits HIV‐1 replication in cellular models
Article in FEBS Letters (May 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in FEBS Letters (May 2024)
Article in Nature Medicine (November 2023)
Article in PLOS ONE (February 2023)